Trials / Not Yet Recruiting
Not Yet RecruitingNCT07131904
Non-alcoholic, Fiber-enriched Beer and Its Effect on Blood Glucose Concentration
Non-alcoholic, Fiber-enriched Beer and Its Effect on Blood Glucose Concentration: A Scientific Study
- Status
- Not Yet Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 25 (estimated)
- Sponsor
- David Faeh · Academic / Other
- Sex
- All
- Age
- 18 Years – 60 Years
- Healthy volunteers
- Accepted
Summary
This study examines how various non-alcoholic beverages affect blood sugar levels. The beverages are a non-alcoholic, fiber-enriched beer, a conventional non-alcoholic beer, and a sugar solution. Participants drink one of these beverages on different days. Afterwards, a sensor on the upper arm is used to measure the sugar content in the body fluid under the skin over a period of two hours. The aim is to find out how much blood sugar concentration rises after drinking. This will be used to check whether the non-alcoholic, fiber-enriched beer has a more favorable effect on sugar metabolism than conventional beverages. Participation is voluntary, and the data will be treated confidentially.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | non-alcoholic, fiber-enriched beer (FEB) | 500 ml FEB consumed once during a test day in a randomized crossover design. Postprandial blood glucose is monitored for 120 minutes using a continuous glucose monitor (FreeStyle Libre 3). |
| OTHER | conventional, non-alcoholic beer | 500 ml conventional non-alcoholic beer consumed once during a test day in a randomized crossover design. Postprandial blood glucose is monitored for 120 minutes using a continuous glucose monitor (FreeStyle Libre 3). |
| OTHER | glucose solution | Glucose solution containing 12.5 g glucose in 500 ml water, consumed once during a test day in a randomized crossover design. Postprandial blood glucose is monitored for 120 minutes using a continuous glucose monitor (FreeStyle Libre 3). |
Timeline
- Start date
- 2025-08-12
- Primary completion
- 2025-09-22
- Completion
- 2025-10-15
- First posted
- 2025-08-20
- Last updated
- 2025-08-20
Source: ClinicalTrials.gov record NCT07131904. Inclusion in this directory is not an endorsement.